HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lichen sclerosus of the vulva. Long-term steroid maintenance therapy.

AbstractOBJECTIVE:
To assess the efficacy of graduated topical steroids for long-term maintenance therapy for vulvar lichen sclerosus.
STUDY DESIGN:
A prospective observational study was performed in the Gynaecological Oncology Department, City Hospital, Birmingham, U.K. Fifty-four patients were recruited for the study. The diagnosis was confirmed with histopathologic examination. After confirmation of the diagnosis, patients were started on a diminishing regimen of topical steroid.
RESULTS:
Of the 54 patients in the study, 51 responded to the steroid regimen, and three did not.
CONCLUSION:
The graduated topical steroid regimen has a high response rate and takes a relatively short time to achieve, justifying the use of graduated topical steroids for this condition. Graduated dose reduction allows the majority of patients to remain in asymptomatic remission and minimize steroid exposure.
AuthorsP Sinha, O Sorinola, D M Luesley
JournalThe Journal of reproductive medicine (J Reprod Med) Vol. 44 Issue 7 Pg. 621-4 (Jul 1999) ISSN: 0024-7758 [Print] United States
PMID10442326 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Betamethasone
  • Clobetasol
Topics
  • Administration, Cutaneous
  • Adult
  • Anti-Inflammatory Agents (administration & dosage, therapeutic use)
  • Betamethasone (administration & dosage, therapeutic use)
  • Clobetasol (administration & dosage, therapeutic use)
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Glucocorticoids
  • Humans
  • Lichen Sclerosus et Atrophicus (drug therapy)
  • Middle Aged
  • Prospective Studies
  • Treatment Outcome
  • Vulvar Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: